Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
1.350
-0.100 (-6.90%)
At close: Mar 6, 2026, 4:00 PM EST
1.360
+0.010 (0.74%)
After-hours: Mar 6, 2026, 7:48 PM EST
Acurx Pharmaceuticals Market Cap
Acurx Pharmaceuticals has a market cap or net worth of $3.44 million as of March 6, 2026. Its market cap has decreased by -74.15% in one year.
Market Cap
3.44M
Enterprise Value
-2.47M
1-Year Change
-74.15%
Ranking
Category
Stock Price
$1.35
Market Cap Chart
Since the IPO on June 25, 2021, Acurx Pharmaceuticals's market cap has decreased from $57.25M to $3.44M, a decrease of -93.99%. That is a compound annual growth rate of -45.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 3.44M | -41.20% |
| Dec 31, 2025 | 5.85M | -57.48% |
| Dec 31, 2024 | 13.75M | -73.92% |
| Dec 29, 2023 | 52.73M | 14.29% |
| Dec 30, 2022 | 46.14M | 4.51% |
| Dec 31, 2021 | 44.15M | -22.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galmed Pharmaceuticals | 4.34M |
| Indaptus Therapeutics | 4.15M |
| Decoy Therapeutics | 4.03M |
| Matinas BioPharma Holdings | 3.85M |
| Oragenics | 3.84M |
| GRI Bio | 3.71M |
| HCW Biologics | 3.57M |
| SciSparc | 3.15M |